Skip to main content

Animations

MJFF Publications

5991 - 6000 of 8399 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • OPEN
    Title: Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
    Journal Name: Archives of Toxicology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00204-018-2222-z
    Citation Count: 19
  • OPEN
    Title: Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0255-7
    Citation Count: 51
  • RESTRICTED
    Title: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6
    Best OA location URL:
    Citation Count: 55
  • OPEN
    Title: Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia
    Journal Name: American Journal of Physiology-Heart and Circulatory Physiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/ajpheart.00206.2018
    Citation Count: 11
  • OPEN
    Title: Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy157
    Citation Count: 68
  • RESTRICTED
    Title: Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.009
    Best OA location URL:
    Citation Count: 111
  • OPEN
    Title: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020
    Citation Count: 25
  • OPEN
    Title: Testing a longitudinal compensation model in premanifest Huntington’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awy122
    Citation Count: 40
  • OPEN
    Title: Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease
    Journal Name: Journal of Tissue Engineering and Regenerative Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/term.2698
    Citation Count: 58
  • OPEN
    Title: α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.201798878
    Citation Count: 84
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.